Search
Search Results
##search.searchResults.foundPlural##
-
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4644Suppl. Files: 1264PDF: 1164Html: 318 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4995PDF: 1891HTML: 2885Untitled: 306 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1664PDF: 1097HTML: 148 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
254PDF: 237HTML: 109 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1618PDF: 971HTML: 1027figures: 235table 1: 236table2: 237table3: 246 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4474PDF: 1273HTML: 2461Figure 1: 224 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1872PDF: 612HTML: 17001Figure 4: 215Figure 3: 189Figure 2: 190Figure 1: 222 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2784PDF: 1259HTML: 289 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1670PDF: 907HTML: 1089Picture 1: 221 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4675PDF: 1567HTML: 8551 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1336PDF: 1006HTML: 353 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1550PDF: 894HTML: 3147 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1566PDF: 1410HTML: 122 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3927PDF: 1700HTML: 879Figures . Eliassian: 301 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1275PDF: 890HTML: 2200Figue 1: 212 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2249PDF: 1132HTML: 328 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1965PDF: 909HTML: 1669 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2685PDF: 907HTML: 9070Efremov 1: 276Efremov 2: 246 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2312PDF: 2026HTML: 536 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
1018PDF: 735Suppl. Files: 158HTML: 193 -
Stroke in a patient with tuberculous meningitis and HIV infection
1810PDF: 877HTML: 1891figure 1: 209 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1494PDF: 975HTML: 433 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3545PDF: 632HTML: 733 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1416PDF: 548HTML: 446 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2809PDF: 1120HTML: 5129Cover Letter: 208Figure 2: 216Figure 1: 222Figure 3: 246Figure 4: 217Figure Legend: 234Table 1: 246Table 2: 230Table 3: 225 -
WHAT ARE FUNGAL INFECTIONS?
4415PDF: 2513HTML: 27710de Pauw: 296







